Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 554 followers.

RT @CDocAmianto: #curaericerca La somministrazione intrapleurica di SEPREHVIR in pazienti con #mesotelioma induce una valida... https://t.c…

#curaericerca La somministrazione intrapleurica di SEPREHVIR in pazienti con #mesotelioma induce una valida... https://t.co/quOMq515Dm

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.